| 2021 |
Metzger CE, Swallow EA, Stacy AJ, Tippen SP, Hammond MA, Chen NX, Moe SM, Allen MR. Reversing cortical porosity: cortical pore infilling in preclinical models of chronic kidney disease. Bone. February 2021;143:115632. |
5 |
0 |
| 2021 |
Tippen SP, Noonan ML, Ni P, Metzger CE, Swallow EA, Sacks SA, Chen NX, Thompson WR, Prideaux M, Atkins GJ, Moe SM, Allen MR, White KE. Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. May 2021;146:115885. |
4 |
2 |
| 2021 |
Metzger CE, Swallow EA, Stacy AJ, Allen MR. Strain-specific alterations in the skeletal response to adenine-induced chronic kidney disease are associated with differences in parathyroid hormone levels. Bone. July 2021;148:115963. |
5 |
1 |
| 2022 |
Tippen SP, Metzger CE, Swallow EA, Sacks SA, Wallace JM, Allen MR. The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype. Bone. January 2022;154:116228. |
1 |
0 |
| 2022 |
Swallow EA, Metzger CE, Newman CL, Chen NX, Moe SM, Allen MR. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease. Bone. April 2022;157:116340. |
2 |
0 |
| 2022 |
Damrath JG, Metzger CE, Allen MR, Wallace JM. A novel murine model of combined insulin-dependent diabetes and chronic kidney disease has greater skeletal detriments than either disease individually. Bone. December 2022;165:116559. |
3 |
0 |
| 2023 |
Surowiec RK, Saldivar R, Rai RK, Metzger CE, Jacobson AM, Allen MR, Wallace JM. Ex vivo exposure to calcitonin or raloxifene improves mechanical properties of diseased bone through non-cell mediated mechanisms. Bone. August 2023;173:116805. |
1 |
0 |
| 2023 |
Newman CL, Surowiec RK, Swallow EA, Metzger CE, Kim J, Tomaschke AA, Chen NX, Allen MR, Wallace JM, Moe SM, Wu Y-C, Niziolek PJ. Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease. Bone. August 2023;173:116808. |
0 |
0 |
| 2020 |
Metzger CE, Swallow EA, Allen MR. Elevations in cortical porosity occur prior to significant rise in serum parathyroid hormone in young female mice with adenine-induced CKD. Calcif Tiss Int. April 2020;106(4):392-400. |
6 |
2 |
| 2020 |
Chen NX, Srinivasan S, O'Neill K, Nickolas TL, Wallace JM, Allen MR, Metzger CE, Creecy A, Avin KG, Moe SM. Effect of advanced glycation end‐products (AGE) lowering drug ALT‐711 on biochemical, vascular, and bone parameters in a rat model of CKD‐MBD. J Bone Miner Res. March 2020;35(3):608-617. |
4 |
4 |